Cardiovascular Diseases Clinical Trial
Official title:
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Verified date | February 14, 2017 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
African Americans have a higher prevalence of vascular disease than Caucasians. Vascular
disease can lead to heart attacks, strokes and even amputations. Insulin, a hormone which is
secreted by the pancreas, affects not only glucose and fat metabolism but also vascular
disease. Impairment of insulin s ability to remove glucose from the circulation is known as
insulin resistance. To overcome insulin resistance the pancreas secretes extra insulin. These
high levels of insulin affect circulating triglyceride levels by both promoting production of
triglyceride by the liver and interfering with clearance of triglyceride from the
circulation. Triglyceride in turn contributes to the development of vascular disease by
causing both inflammation and hypercoagulability.
Surprisingly African Americans are more insulin resistant and have a higher rate of vascular
disease than Caucasians but have lower triglyceride levels. Because of the high rate of
vascular diseases in African Americans, our aim is to determine if the adverse effects of
triglyceride occur at a lower level in African Americans than Caucasians. To achieve this
goal we will determine if there are differences in the effect of a meal on triglyceride
levels and vascular function in a representative cohort of African American and Caucasian
women.
For this study we will enroll 96 women (48 African American and 48 Caucasian women). We are
recruiting women because ethnic differences in triglyceride are even greater in women than
men. We are enrolling women between the ages of 18 and 65 years. The study will involve
several outpatient visits to the NIH Clinical Center. The first visit will be a screening to
determine eligibility. At the second visit a test to measure insulin resistance will be
performed. This test is called a frequently sampled intravenous glucose tolerance test. The
third visit will be for the test meal. Before and at 2, 4 and 6 hours after the meal, blood
will be drawn and vascular function measured. Vascular function is determined by taking blood
pressure and then measuring blood flow in the arm with ultrasound. It is possible that
individual differences in diet could affect the results of the vascular study on the day of
the test meal. Therefore for 7 days prior to the test meal, the NIH Clinical Center will
provide to each participant all their meals in the form of either trays or meals in a box.
These meals will be consistent with the typical American diet and be 33% fat, 15% protein and
52% carbohydrate. In designing these meals, the dietician will take into account individual
food preferences.
This study is being performed in collaboration with the Harvard School of Public Health, the
University of Texas Southwestern Medical Center and Indiana University. Therefore some blood
drawn during Visits 2 and 3 will be sent coded, without personal identifiers, to each
institution for analyses.
...
Status | Completed |
Enrollment | 47 |
Est. completion date | February 14, 2017 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA: African American Women: Individuals will be considered to be African American if they self-identify as African American and were born in the United States. Further they must describe both parents as being African American. Caucasian Women: Individuals will be considered to be Caucasian if they self-identify as Caucasian. Healthy Volunteers: The potential enrollee must self identify as a normal volunteer and have this confirmed by having at the screening visit a normal complete blood count, glucose, BUN creatinine, liver and thyroid panel. Age between 18 and 65 years: This age range is chosen because TG levels across the lifespan from early adulthood through to postmenopausal status. Weare using 65 years of age as a conventional upper limit. In addition, 65 years of age has been used as an age category cut-off by National Health and Nutrition Examination Surveys. Our goal is to detect ethnic differences in the pathways that allow vascular disease to develop. Enrolling women between the ages of 18 and 65 years, maximizes our ability to detect differences in mechanism of action that are truly secondary to ethnicity. Weight less than 136 kg (300 lbs): This weight restriction is necessitated by the limitations of the DXA scanner. The DXA platform cannot accommodate subjects who weigh more than 136 kg. BMI between 20 and 45 kg/m2: Women in both ethnic groups will be recruited across BMI nonobese and obese categories. Therefore we will enroll approximately equal numbers of women from each ethnic group in both BMI categories BMI between 20 and 30 kg/m(2) and BMI between 30 and 45 kg/m(2). EXCLUSION CRITERIA: Refusal to agree to use barrier contraception: The DXA scan and CT scan should not be performed if the participant is pregnant. In addition, TG levels are directly affected by pregnancy. Even though we will perform pregnancy tests within 7 days of each visit, we also require that the subject agree to abstinence or barrier contraception throughout the study. Medications which affect parameters under investigation: Examples include corticosteroids, oral contraceptives, hypoglycemic (oral or injection), hypolipidemic, antihypertensive and antipsychotic agents. Oral contraceptives, in particular, are exclusion criteria because the estrogen component of oral contraceptives increase TG levels and would therefore obscure the effect of the test meal on TG levels. Medical Conditions which affect parameters under investigation: Examples include diabetes, thyroid disease, liver disease, pancreatitis, nephrotic syndrome. Hispanics: The relationship between TG and insulin resistance in Hispanic White women is midway between African American and Caucasian women. Therefore in this initial study to be able to determine the maximum ethnic difference in the relationship between TG and insulin resistance, we will enroll in this protocol study women who self-identify as African American and Caucasian and not enroll women who self-identify as Hispanic. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Ferdinand KC. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol. 2006 Jan 16;97(2A):12A-19A. Epub 2005 Dec 1. Review. — View Citation
Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia. 1976 Dec;12(6):563-71. — View Citation
Schwartz EA, Reaven PD. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am. 2006 Sep;35(3):525-49, viii. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in endothelial function after a meal. | |||
Secondary | Ability of the presence or absence of insulin resistance to predict change in endothelial function after a meal. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|